# Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)

> **NCT02902861** · PHASE3 · COMPLETED · sponsor: **Prof. Kristian Reich** · enrollment: 120 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Placebo ( for Methotrexate)

## Key facts

- **NCT ID:** NCT02902861
- **Lead sponsor:** Prof. Kristian Reich
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-09
- **Final completion:** 2015-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02902861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02902861, "Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02902861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*